| Ticker: TWLB | 2120 Smithtown Avenue | |
| Exchange: New York Stock Exchange | Ronkonkoma, New York 11779 | |
| Industry: Manufacturing | (516) 467-3140 |
| Type of Shares: | Common Shares | Filing Date: | 6/5/96 | |
| U.S. Shares: | 6,800,000 | Offer Date: | 11/15/96 | |
| Non-U.S. Shares: | 1,700,000 | Filing Price: | $12.00 | |
| Primary Shares: | 8,500,000 | Offer Price: | $12.00 | |
| Secondary Shares: | 0 | Gross Spread: | $0.78 | |
| Offering Amount: | $102,000,000 | Selling: | $0.46 | |
| Expenses: | - | Reallowance: | $0.10 | |
| Shares Out After: | 26,500,000 |
| Manager | Tier | Phone |
| Donaldson, Lufkin & Jenrette Securities Corp. | Lead Manager | (212) 504-4525 |
| Bear, Stearns & Co. Inc. | Co-manager | (212) 272-2000 |
| Merrill Lynch & Co. | Co-manager | (212) 449-4600 |
| Montgomery Securities | Co-manager | (415) 627-2220 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/31/95 | 3/31/96 | 3/31/95 | 3/31/96 | ||
| Revenue: | $148.74 | $43.98 | $36.13 | Assets: | $85.15 |
| Net Income: | $18.40 | $5.96 | $3.86 | Liabilities: | $22.69 |
| EPS: | $40.90 | $13.24 | $8.58 | Equity: | $62.46 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company manufactures and markets brand name nutritional supplements sold through independent health food stores. Since the Company's founding in 1968 by David and Jean Blechman, the Company has emphasized the development and introduction of high-quality, unique products in response to emerging trends in the nutritional supplement industry. The Company produces a full line of nutritional supplements and offers the broadest product line in the industry with more than 800 products and 1500 stockkeeping units. The Company's product line includes vitamins, minerals, amino acids, fish and marine oils, sports nutrition products and special formulas marketed under the TWINLAB (R) trademark and a full line of herbal supplements and phytonutrients and herb teas marketed under the Nature's Herbs (R) and Alvita (R) trademarks, respectively. None of the Company's products individual accounted for more than 7% of total net sales in 1995. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to redeem all of the company's outstanding preferred shares and to repay debt. The balance of the net proceeds of the offering will be used for general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.